AN OPEN-LABEL, RANDOMIZED, ADAPTIVE, TWO-ARM, MULTICENTE

Project: Research project

Description

AN OPEN-LABEL, RANDOMIZED, ADAPTIVE, TWO-ARM, MULTICENTER TRIAL TO EVALUATE PHARMACOKINETICS AND PHARMACODYNAMICS OF TWO DOSES OF OSELTAMIVIR (TAMIFLU) IN THE TREATMENT OF INFLUENZA IN IMMUNOCOMPROMISED CHILDREN LESS THAN 13 YEARS OF AGE, WITH
StatusActive
Effective start/end date8/1/166/30/20

Funding

  • HOFFMANN-LA ROCHE PHARMACEUTICALS

Fingerprint

Oseltamivir
Human Influenza
Multicenter Studies
Pharmacokinetics
Therapeutics